(Q37549985)

21 August 2017

Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes (English)

1 reference

21 August 2017

1 reference

1 reference

8

Anat Loewenstein

1 reference

21 August 2017

Elad Moisseiev

1

1 reference

21 August 2017

Michael Waisbourd

2

1 reference

21 August 2017

Elad Ben-Artsi

3

1 reference

21 August 2017

Eliya Levinger

4

1 reference

21 August 2017

Adiel Barak

5

1 reference

21 August 2017

Tad Daniels

6

1 reference

21 August 2017

Karl Csaky

7

1 reference

21 August 2017

Irina S Barequet

9

1 reference

21 August 2017

31 October 2013

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

21 August 2017

1 reference

21 August 2017

252

1 reference

21 August 2017

2

1 reference

21 August 2017

331-337

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

21 August 2017

start time

31 October 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The expanding role of vascular endothelial growth factor inhibitors in ophthalmology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Corneal Melt While Using Topical Bevacizumab Eye Drops

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Mapping of the neonatal Fc receptor in the rodent eye.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

FcRn: the neonatal Fc receptor comes of age.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Corneal penetration of topical and subconjunctival bevacizumab

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

PET/CT imaging of I-124-radiolabeled bevacizumab and ranibizumab after intravitreal injection in a rabbit model.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Bevacizumab application delays epithelial healing in rabbit cornea.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

[Exploration of three-dimensional biometric measurement of emmetropic adult eye-ball by using magnetic resonance imaging technology].

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Safety profile of topical VEGF neutralization at the cornea

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Influence of format on in vitro penetration of antibody fragments through porcine cornea

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912353

Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans

1 September 2018

1 reference

12 December 2020

Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro

1 reference

12 December 2020

The effect of topical bevacizumab on corneal neovascularization

1 reference

12 December 2020

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis

1 reference

12 December 2020

Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome

1 reference

12 December 2020

Age-related macular degeneration

1 reference

12 December 2020

Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes

1 reference

12 December 2020

Pharmacokinetics of intravitreal bevacizumab (Avastin)

1 reference

12 December 2020

INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 mg VERSUS 3.0 mg OF BEVACIZUMAB IN HUMANS

1 reference

12 December 2020

Topical bevacizumab therapy for corneal neovascularization

1 reference

12 December 2020

Aqueous humor concentration of bevacizumab after subconjunctival injection in rabbit

1 reference

12 December 2020

10.1007/S00417-013-2495-0

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24170282

1 reference